EP 934B - An Innovative Way to Treat Prostate Cancer

Summary: Advances in treatment can help make prostate cancer curable and survivable.
Air Date: 3/19/19
Duration: 27:46
Host: Michael Roizen, MD
Guest Bio: Jonathan Haas, MD
Jonathan Haas, MD, is the Chairman of the Department of Radiation Oncology at Winthrop-University Hospital and Associate Professor of Radiation Oncology at SUNY-Stony Brook School of Medicine. Dr. Haas has been named a Castle Connolly New York Metropolitan Top Doctor as well as New York Newsday Top Doctor and was the youngest Radiation Oncologist to receive these awards.

He is a regular contributing guest on WABC radio in New York and was the first Radiation Oncologist to complete Cyberknife training in the New York metropolitan area. He has published extensively on the use of CyberKnife for Lung, Prostate, Spine/CNS, and Gynecologic uses for CyberKnife. Dr. Haas has taught physicians in this country and abroad on clinical utilization of CyberKnife and his Department at Winthrop is the largest CyberKnife practice in the United States. His primary research interests are the use of CyberKnife for prostate and breast cancer.
EP 934B - An Innovative Way to Treat Prostate Cancer
Prostate cancer is the second most common cancer for men in the United States. About one in nine will be diagnosed during his lifetime.

Thankfully, advances in treatment can help make this disease curable and survivable.

Dr. Jonathan Haas discusses the CyberKnife—robotic technology that delivers highly targeted beams of radiation to tumors, while sparing healthy tissue. It's so precise that it can track your body's movement when you breathe and adjust the beams to stay focused on the tumor.

This gives hope to patients with tumors that were previously thought to be inoperable due to damaging side effects from conventional radiation.

Tune in to learn more about who can benefit from this life-saving treatment.

How Interval Training Can Lower Your RealAge
More from this show . . .

EP 934 News of the WeekEP 935 News of the Week